- Home
- CTXR vs TOPS Comparison
CTXR vs TOPS Comparison
Compare CTXR & TOPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTXR | TOPS |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1M | 24.0M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | CTXR | TOPS |
|---|---|---|
| Price | $0.71 | $4.98 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 491.0K | 5.3K |
| Earning Date | 02-13-2026 | 10-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.30 |
| Revenue | $3,944,111.00 | ★ $87,872,000.00 |
| Revenue This Year | N/A | $9.90 |
| Revenue Next Year | $147.57 | N/A |
| P/E Ratio | ★ N/A | $2.14 |
| Revenue Growth | N/A | ★ 4.77 |
| 52 Week Low | $0.63 | $4.45 |
| 52 Week High | $2.97 | $11.47 |
Technical Indicators
Market Signals| Indicator | CTXR | TOPS |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 46.19 |
| Support Level | $0.70 | $4.78 |
| Resistance Level | $0.95 | $5.10 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 10.92 | 34.01 |
Price Performance
Historical ComparisonAbout CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.